The Definition and Prevalence of Obesity and Metabolic Syndrome: Correlative Clinical Evaluation Based on Phenotypes.
肥胖和代謝綜合症的定義與流行病學:基於表現型的相關臨床評估。
Adv Exp Med Biol 2024-09-17
Lipopolysaccharide accelerates peristalsis by stimulating glucagon-like peptide-1 release from L cells in the rat proximal colon.
脂多醣通過刺激大鼠近端結腸 L 細胞釋放胰高血糖素樣肽-1 來加速蠕動。
J Physiol 2024-09-17
Glucagon-like Receptor-1 agonists for obesity: Weight loss outcomes, tolerability, side effects, and risks.
針對肥胖的胰高血糖素樣受體-1激動劑:體重減輕結果、耐受性、副作用及風險。
Obes Pillars 2024-09-17
Effect of surgical, medical, and behavioral weight loss on hormonal and sexual function in men: a contemporary narrative review.
男性手術、藥物及行為減重對荷爾蒙和性功能的影響:一篇當代敘述性綜述。
Ther Adv Urol 2024-09-17
Testosterone and the prevention of type 2 diabetes mellitus: therapeutic implications from recent trials.
睪固酮與2型糖尿病的預防:近期試驗的治療意涵。
Curr Opin Endocrinol Diabetes Obes 2024-09-17
Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide "For Research Purposes".
繞過開處方醫師和藥劑師:線上購買 Semaglutide 和 Tirzepatide「用於研究目的」。
Ann Pharmacother 2024-09-17
A cost comparison of GLP-1 receptor agonists and bariatric surgery: what is the break even point?
GLP-1 受體激動劑與減重手術的成本比較:損益平衡點在哪裡?
Surg Endosc 2024-09-16
Treatment trajectories for Danish individuals with type 2 diabetes in the era of emerging glucose-lowering therapies.
新興降糖療法時代丹麥2型糖尿病患者的治療軌跡。
Diabetes Obes Metab 2024-09-16